Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutati
ClinicalTrials.gov study NCT07010419. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients
ClinicalTrials.gov study NCT04552613. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical S
ClinicalTrials.gov study NCT07182682. IPD Sharing: NO. Countries: 1. Publications: 0.
S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC
ClinicalTrials.gov study NCT03457337. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation
ClinicalTrials.gov study NCT01516983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
ClinicalTrials.gov study NCT04590664. IPD Sharing: NO. Countries: 1. Publications: 0.
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
ClinicalTrials.gov study NCT02321293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC
ClinicalTrials.gov study NCT04797806. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer Drugs
ClinicalTrials.gov study NCT06863818. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC
ClinicalTrials.gov study NCT05223595. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT02820116. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02520778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions
ClinicalTrials.gov study NCT04363242. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation
ClinicalTrials.gov study NCT06956001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors
ClinicalTrials.gov study NCT06022276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors
ClinicalTrials.gov study NCT01137162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
ClinicalTrials.gov study NCT06415487. IPD Sharing: NO. Countries: 2. Publications: 0.
Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)
ClinicalTrials.gov study NCT03146338. IPD Sharing: NO. Countries: 1. Publications: 0.
ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
ClinicalTrials.gov study NCT06714357. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT01718847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.